MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
Image Building | Visual Branding
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
There are over 1,000 life science industry conferences scheduled around the world each year... Learn More
08/28/14 - OncoPep Raises $6.9 Million Series B Financing to Advance Novel Cancer Vaccines and Expands Phase 1/2a Clinical Trial
08/19/14 - OmedaRx and GNS Healthcare Announce Deployment of Next-Generation Medication Adherence Platform
08/12/14 - FORMA Therapeutics and Paradigm Announce Molecular Profiling Collaboration for Drug Candidates
MacDougall Biomedical Clients in San Francisco
Come and schedule meetings with our clients during the week of January 13-16, 2014